ZIOPHARM Oncology Inc is a pharmaceutical company based in New York, New York, specializing in the development of innovative therapies for cancer treatment. Located in the heart of the city at 1180 6th Avenue, this company focuses on advancing medical research and pharmaceutical solutions aimed at improving patient outcomes in oncology. The organization operates within the competitive pharmaceutical sector, contributing to the ongoing efforts to discover and develop new drugs that target various forms of cancer.
As a pharmaceutical company, ZIOPHARM Oncology Inc engages in rigorous scientific research and clinical trials to evaluate the safety and effectiveness of its therapies. The company’s work involves collaboration with healthcare professionals, researchers, and regulatory agencies to ensure that its products meet stringent standards. This approach is vital in addressing the complex challenges associated with cancer treatment and drug development.
Situated in New York City, a hub for medical innovation and biotechnology, ZIOPHARM Oncology Inc benefits from access to a diverse talent pool and cutting-edge resources. The location supports the company’s mission by facilitating partnerships and fostering an environment conducive to scientific advancement. With a focus on oncology, ZIOPHARM contributes to the broader pharmaceutical industry’s efforts to enhance the quality of life for patients facing cancer.
ZIOPHARM Oncology Inc can be reached at 646-214-0700, providing a direct line for inquiries related to its pharmaceutical products and research initiatives. The company’s presence in New York positions it as a significant player within the local and national pharmaceutical landscape, working toward the development of novel cancer therapies through dedicated research and innovation.


































